Dirk Kersten - 24 May 2023 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Director, 10%+ Owner
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol
DYN
Transactions as of
24 May 2023
Transactions value $
$0
Form type
4
Filing time
25 May 2023, 18:37:32 UTC
Previous filing
06 Jun 2022
Next filing
11 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +24.9K $0.00 24.9K 24 May 2023 Common Stock 24.9K $13.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 24, 2023. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 24, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.